Literature DB >> 11520767

Impression cytology following mitomycin C therapy for ocular surface squamous neoplasia.

P A McKelvie1, M Daniell.   

Abstract

BACKGROUND/AIMS: Topical mitomycin C (MMC) therapy has been used for treatment of ocular surface squamous neoplasia (OSSN) since 1994. Relatively few studies have reported the cellular changes in ocular surface following MMC.
METHODS: Impression cytology was studied in four patients with ocular surface squamous neoplasia, either primary or recurrence after previous excisional biopsy. The authors studied samples obtained using Millipore filters at intervals between 4 and 17 weeks after commencement of MMC, and compared them with pretreatment cytology.
RESULTS: MMC induced changes of cytomegaly, cytoplasmic vacuolation, nucleomegaly with nuclear wrinkling, and binucleation or multinucleation were seen in some cells in all samples. However, nuclear/cytoplasmic (N/C) ratio in these enlarged cells was normal. These changes mimicked those seen following radiation therapy in uterine cervix. Changes of increased nuclear and cell size with increased N/C ratio were seen in some dysplastic cells. The predominant form of cell death was apoptosis with fewer cells showing necrosis.
CONCLUSIONS: MMC appears to produce cell death in OSSN by apoptosis and necrosis. Cellular changes related to MMC mimic those caused by radiation-cytomegaly, nucleomegaly, and vacuolation. MMC related changes may persist in ocular surface epithelium for at least 8 months following MMC therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11520767      PMCID: PMC1724127          DOI: 10.1136/bjo.85.9.1115

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  17 in total

1.  Who should receive mitomycin-C after pterygium surgery?

Authors:  A Sugar
Journal:  Ophthalmology       Date:  1992-11       Impact factor: 12.079

2.  Improved impression cytology techniques for the immunopathological diagnosis of superficial viral infections.

Authors:  M A Thiel; W Bossart; W Bernauer
Journal:  Br J Ophthalmol       Date:  1997-11       Impact factor: 4.638

3.  Application of impression cytology to the diagnosis of conjunctival neoplasms.

Authors:  G R Nolan; L W Hirst; R G Wright; B J Bancroft
Journal:  Diagn Cytopathol       Date:  1994       Impact factor: 1.582

4.  Cytologic and DNA cytometric diagnosis and therapy monitoring of squamous cell carcinoma in situ and malignant melanoma of the cornea and conjunctiva.

Authors:  B Nadjari; A Kersten; B Ross; H Motherby; R Krallmann; R Sundmacher; A Böcking
Journal:  Anal Quant Cytol Histol       Date:  1999-10       Impact factor: 0.302

5.  Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience.

Authors:  J Frucht-Pery; J Sugar; J Baum; J E Sutphin; J Pe'er; H Savir; E J Holland; D M Meisler; J A Foster; R Folberg; Y Rozenman
Journal:  Ophthalmology       Date:  1997-12       Impact factor: 12.079

6.  Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia.

Authors:  G Tabin; S Levin; G Snibson; M Loughnan; H Taylor
Journal:  Ophthalmology       Date:  1997-03       Impact factor: 12.079

7.  Cytologic changes in the conjunctiva mimicking malignancy after topical mitomycin C chemotherapy.

Authors:  D R Salomão; W D Mathers; J E Sutphin; K Cuevas; R Folberg
Journal:  Ophthalmology       Date:  1999-09       Impact factor: 12.079

8.  Retrospective study of ocular surface squamous neoplasia.

Authors:  G A Lee; L W Hirst
Journal:  Aust N Z J Ophthalmol       Date:  1997-11

9.  The clinical value of urinary cytology: 12 years of experience with 615 patients.

Authors:  U Maier; R Simak; N Neuhold
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

10.  Mitomycin C therapy for corneal intraepithelial neoplasia.

Authors:  J Frucht-Pery; Y Rozenman
Journal:  Am J Ophthalmol       Date:  1994-02-15       Impact factor: 5.258

View more
  7 in total

1.  The clinical value of in vivo confocal microscopy for diagnosis of ocular surface squamous neoplasia.

Authors:  Y Xu; Z Zhou; Y Xu; M Wang; F Liu; H Qu; J Hong
Journal:  Eye (Lond)       Date:  2012-03-09       Impact factor: 3.775

Review 2.  Impression cytology of the ocular surface.

Authors:  R Singh; A Joseph; T Umapathy; N L Tint; H S Dua
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

3.  Topical treatment options for conjunctival neoplasms.

Authors:  Jonathan W Kim; David H Abramson
Journal:  Clin Ophthalmol       Date:  2008-09

4.  Mitomycin C as an adjunct in the treatment of localised ocular surface squamous neoplasia.

Authors:  C Chen; D Louis; T Dodd; J Muecke
Journal:  Br J Ophthalmol       Date:  2004-01       Impact factor: 4.638

5.  Comparison of standard and low dose intraoperative mitomycin C in prevention of corneal hazeafter photorefractive keratectomy.

Authors:  Hassan Razmjoo; Mohammad Reza Kooshanmehr; Alireza Peyman; Zahra Kor; Erfan Mohammadesmaeil
Journal:  Int J Prev Med       Date:  2013-02

Review 6.  Ocular surface squamous neoplasia: management and outcomes.

Authors:  Roland Hӧllhumer; Susan Williams; Pamela Michelow
Journal:  Eye (Lond)       Date:  2021-02-09       Impact factor: 4.456

7.  Histopathological change of oral malignant tumour and epithelial dysplasia subjected to photodynamic therapy.

Authors:  Masataka Uehara; Hisazumi Ikeda; Mihoko Nonaka; Izumi Asahina
Journal:  J Oral Maxillofac Res       Date:  2010-10-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.